Sonendo (SONX) Stock Price, News & Analysis

Company Overview

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.01 to $1.15
• 52-Week Range: $0.01 to $15.34
• Volume: 106 shs
• Average Volume: 962 shs
• Market Capitalization: $13.94 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Sonendo Stock Analysis - MarketRank™

Sonendo scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sonendo.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sonendo is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sonendo is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Sonendo has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.03% of the float of Sonendo has been sold short.

Short Interest Ratio / Days to Cover

Sonendo has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sonendo has recently decreased by 80.00%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sonendo does not currently pay a dividend.

Dividend Growth

Sonendo does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.03% of the float of Sonendo has been sold short.

Short Interest Ratio / Days to Cover

Sonendo has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sonendo has recently decreased by 80.00%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.40

News Sentiment

Sonendo has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sonendo this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sonendo insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 7.90% of the stock of Sonendo is held by insiders.

Percentage Held by Institutions

Only 28.68% of the stock of Sonendo is held by institutions.

SONX Stock Analysis - Frequently Asked Questions

How have SONX shares performed this year?

Sonendo's stock was trading at $1.81 at the beginning of 2025. Since then, SONX stock has decreased by 98.2% and is now trading at $0.0325.

How were Sonendo's earnings last quarter?

Sonendo, Inc. (NYSE:SONX) posted its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.04. The company had revenue of $8.31 million for the quarter, compared to the consensus estimate of $7.60 million. Sonendo had a negative trailing twelve-month return on equity of 184.01% and a negative net margin of 92.74%.

When did Sonendo IPO?

Sonendo (SONX) raised $125 million in an initial public offering on Friday, October 29th 2021. The company issued 7,800,000 shares at $15.00-$17.00 per share.

How do I buy shares of Sonendo?

Shares of SONX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Sonendo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sonendo investors own include Avino Silver & Gold Mines (ASM), Taiwan Semiconductor Manufacturing (TSM), XPeng (XPEV), nCino (NCNO), PayPal (PYPL), Construction Partners (ROAD) and Tenet Healthcare (THC).

Company Calendar

• Last Earnings: 8/07/2024
• Today: 8/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Dental equipment & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:SONX
• CIK: 1407973
• Web: www.sonendo.com
• Phone: 949-766-3636
• Fax: N/A
• Employees: 250
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($59.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$60.92 million
• Net Margins: -92.74%
• Pretax Margin: -105.16%
• Return on Equity: -184.01%
• Return on Assets: -68.60%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 1.82
• Quick Ratio: 1.22

Sales & Book Value

• Annual Sales: $44.40 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $89.42 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 429,000
• Free Float: 393,000
• Market Cap: $13.94 thousand
• Optionable: Not Optionable
• Beta: 1.35